S, B., A, A., AH, M., IR, N., S, S., N, F., . . . R, K. (2026). Efficacy and safety of 2-4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta-analysis. PCN reports : psychiatry and clinical neurosciences, 5(2), e70332. https://doi.org/10.1002/pcn5.70332
Chicago Style (17th ed.) CitationS, Bano, et al. "Efficacy and Safety of 2-4 mg Brexpiprazole in the Management of Schizophrenia: A Systematic Review and Meta-analysis." PCN Reports : Psychiatry and Clinical Neurosciences 5, no. 2 (2026): e70332. https://doi.org/10.1002/pcn5.70332.
MLA (9th ed.) CitationS, Bano, et al. "Efficacy and Safety of 2-4 mg Brexpiprazole in the Management of Schizophrenia: A Systematic Review and Meta-analysis." PCN Reports : Psychiatry and Clinical Neurosciences, vol. 5, no. 2, 2026, p. e70332, https://doi.org/10.1002/pcn5.70332.